CAR-T Cell Therapy for Blood Cancer

The provider administers chimeric antigen receptor T–cell (CAR–T) therapy, genetically modified T cells extracted from a patient’s own blood, by intravenous infusion to a patient to treat leukemia and other types of blood cancer. Choose a location to see hospital-reported price summaries. This page does not show national, sample, or aggregate pricing.